Active ingredients: normal immunoglobulin
What it is used for
KIOVIG administered intravenously is indicated for: (1) Replacement therapy indications - Primary immunodeficiency disorders (PID); - Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. (2) Immunomodulation indications - Idiopathic thrombocytopenia purpura (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count; - Guillain Barre syndrome; - Kawasaki Disease. - Multifocal Motor Neuropathy KIOVIG administered subcutaneously is indicated for: (1) Replacement therapy indications - Primary immunodeficiency disorders (PID);
How to take it
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
The solution should be relatively clear with a slight opalescense.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems